0001209191-22-020285.txt : 20220321 0001209191-22-020285.hdr.sgml : 20220321 20220321171804 ACCESSION NUMBER: 0001209191-22-020285 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220321 FILED AS OF DATE: 20220321 DATE AS OF CHANGE: 20220321 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kaye Randall CENTRAL INDEX KEY: 0001350416 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40192 FILM NUMBER: 22756396 MAIL ADDRESS: STREET 1: 11388 SORRENTO VALLEY ROAD STREET 2: STE. 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Longboard Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001832168 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 845009619 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4275 EXECUTIVE SQUARE STREET 2: SUITE 950 CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: 619-592-9775 MAIL ADDRESS: STREET 1: 4275 EXECUTIVE SQUARE STREET 2: SUITE 950 CITY: LA JOLLA STATE: CA ZIP: 92037 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-03-21 0 0001832168 Longboard Pharmaceuticals, Inc. LBPH 0001350416 Kaye Randall 4275 EXECUTIVE SQUARE SUITE 950 LA JOLLA CA 92037 0 1 0 0 CMO Stock Option (Right to Buy) 6.00 2022-03-21 4 A 0 206500 0.00 A 2032-03-20 Voting common stock 206500 206500 D 1/4th of the shares subject to the stock option vest on March 21, 2023, and the remaining shares vest in 36 equal monthly installments thereafter. /s/ Brandi L. Roberts, Attorney-In-Fact 2022-03-21